Style | Citing Format |
---|---|
MLA | Janani M, et al.. "Association of Future Cancer Metastases With Fibroblast Activation Protein-Α: A Systematic Review and Meta-Analysis." Frontiers in Oncology, vol. 14, no. , 2024, pp. -. |
APA | Janani M, Poorkhani A, Amiriani T, Donyadideh G, Ahmadi F, Jorjanisorkhankalateh Y, Beheshtinia F, Kalaei Z, Roudbaraki M, Soltani M, Khori V, Alizadeh AM (2024). Association of Future Cancer Metastases With Fibroblast Activation Protein-Α: A Systematic Review and Meta-Analysis. Frontiers in Oncology, 14(), -. |
Chicago | Janani M, Poorkhani A, Amiriani T, Donyadideh G, Ahmadi F, Jorjanisorkhankalateh Y, Beheshtinia F, et al.. "Association of Future Cancer Metastases With Fibroblast Activation Protein-Α: A Systematic Review and Meta-Analysis." Frontiers in Oncology 14, no. (2024): -. |
Harvard | Janani M et al. (2024) 'Association of Future Cancer Metastases With Fibroblast Activation Protein-Α: A Systematic Review and Meta-Analysis', Frontiers in Oncology, 14(), pp. -. |
Vancouver | Janani M, Poorkhani A, Amiriani T, Donyadideh G, Ahmadi F, Jorjanisorkhankalateh Y, et al.. Association of Future Cancer Metastases With Fibroblast Activation Protein-Α: A Systematic Review and Meta-Analysis. Frontiers in Oncology. 2024;14():-. |
BibTex | @article{ author = {Janani M and Poorkhani A and Amiriani T and Donyadideh G and Ahmadi F and Jorjanisorkhankalateh Y and Beheshtinia F and Kalaei Z and Roudbaraki M and Soltani M and Khori V and Alizadeh AM}, title = {Association of Future Cancer Metastases With Fibroblast Activation Protein-Α: A Systematic Review and Meta-Analysis}, journal = {Frontiers in Oncology}, volume = {14}, number = {}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Janani M AU - Poorkhani A AU - Amiriani T AU - Donyadideh G AU - Ahmadi F AU - Jorjanisorkhankalateh Y AU - Beheshtinia F AU - Kalaei Z AU - Roudbaraki M AU - Soltani M AU - Khori V AU - Alizadeh AM TI - Association of Future Cancer Metastases With Fibroblast Activation Protein-Α: A Systematic Review and Meta-Analysis JO - Frontiers in Oncology VL - 14 IS - SP - EP - PY - 2024 ER - |